Skip to main content
. 2022 Sep 29;12:975643. doi: 10.3389/fonc.2022.975643

Table 4.

Investigator assessed RECIST v1.1 response by Dose Level.

Level 1 Level 2 Level 3 Level 4 All Levels
Complete Response (CR) 0 0 0 0 0
Partial Response (PR) 0 0 0 0 0
Stable Disease (SD) 2/3
(66.7%)
6/20
(30.0%)
2/5
(40.0%)
1/1
(100%)
11/29 (38.0%)
Progressive Disease (PD) 1/3 (33.3%) 14/20
(70.0%)
3/5 (60.0%) 0 17/29 (62.0%)
Overall Response Rate (ORR) 0 0 0 0 0
Median Time to Progression (range) 3.4 months
(1.2-10.8)
1.7 months (0.9-5.5) 3.7 months (0.9-6.2) Not Applicable
Median duration of Stable Disease 7.1 months 4.1 months 4.9 months Not Applicable